Identification of basic residues involved in drug export function of human multidrug resistance-associated protein 2

被引:69
作者
Ryu, S
Kawabe, T
Nada, S
Yamaguchi, A
机构
[1] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan
[2] Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan
[3] Japan Sci & Technol Corp, CREST, Osaka 5670047, Japan
关键词
D O I
10.1074/jbc.M005149200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multidrurg resistance-associated protein 2 (MRPS)/canalicular multispecific organic anion transporter (cMOAT) is involved in the ATP-dependent export of organic anions across the bile canalicular membrane. To identify functional amino acid residues that play essential roles in the substrate transport, each of 13 basic residues around transmembrane regions (TMs) 6-17 were replaced with alanine. Wild type and mutant proteins were expressed in COS-7 cells, and the transport activity was measured as the excretion of glutathione-methylfluorescein. Four mutants, K324A (TM6), K483A (TM9), R1210A (TM16), and R1257A (TM17), showed decreased transport activity, and another mutant, K578A (TM11), showed decreased protein expression. These five mutants were normally delivered to the cell surface similar to the other fully active mutants and wild type MRP2. The importance of TM6, TM16, and TM17 in the transport function of MRP2 is consistent with the previous observation indicating the importance of the corresponding TMI, TM11, and TM12 on P-glycoprotein (Loo, T. W, and Clarke, D. M. (1999) J. Biol. Chem. 274, 35388-35392). Another observation that MRP2 inhibitor, cyclosporine A, failed to inhibit R1230A specifically, indicated the existence of its binding site within TM16.
引用
收藏
页码:39617 / 39624
页数:8
相关论文
共 39 条
[1]   Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain [J].
Bakos, E ;
Evers, R ;
Szakács, G ;
Tusnády, GE ;
Welker, E ;
Szabó, K ;
de Haas, M ;
van Deemter, L ;
Borst, P ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32167-32175
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020
[4]  
Buchler M, 1996, J BIOL CHEM, V271, P15091
[5]   Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter [J].
Chen, ZS ;
Kawabe, T ;
Ono, M ;
Aoki, S ;
Sumizawa, T ;
Furukawa, T ;
Uchiumi, T ;
Wada, M ;
Kuwano, M ;
Akiyama, S .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1219-1228
[6]   OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE [J].
COLE, SPC ;
BHARDWAJ, G ;
GERLACH, JH ;
MACKIE, JE ;
GRANT, CE ;
ALMQUIST, KC ;
STEWART, AJ ;
KURZ, EU ;
DUNCAN, AMV ;
DEELEY, RG .
SCIENCE, 1992, 258 (5088) :1650-1654
[7]   THE ROLE OF THE CANALICULAR MULTISPECIFIC ORGANIC ANION TRANSPORTER IN THE DISPOSAL OF ENDOBIOTICS AND XENOBIOTICS [J].
ELFERINK, RPJO ;
JANSEN, PLM .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (01) :77-97
[8]   HEPATOBILIARY SECRETION OF ORGANIC-COMPOUNDS - MOLECULAR MECHANISMS OF MEMBRANE-TRANSPORT [J].
ELFERINK, RPJO ;
MEIJER, DKF ;
KUIPERS, F ;
JANSEN, PLM ;
GROEN, AK ;
GROOTHUIS, GMM .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1995, 1241 (02) :215-268
[9]   Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA [J].
Evers, R ;
Kool, M ;
van Deemter, L ;
Janssen, H ;
Calafat, J ;
Oomen, LCJM ;
Paulusma, CC ;
Elferink, RPJO ;
Baas, F ;
Schinkel, AH ;
Borsi, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1310-1319
[10]   Multidrug resistance protein -: Identification of regions required for active transport of leukotriene C4 [J].
Gao, M ;
Yamazaki, M ;
Loe, DW ;
Westlake, CJ ;
Grant, CE ;
Cole, SPC ;
Deeley, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10733-10740